Drug recall · May 11, 2022
alprazolam XR extended-release tablets recall
Why: Failed Dissolution Specifications: low out-of-specification dissolution test results observed.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0068-1.
- Lots / codes
Lot # EH8348, exp. date August 2023
- Quantity
- 6,789 bottles
- Company
- Viatris Inc, Canonsburg, PA
- Distribution
- Product was distributed nationwide in the USA
- Initiated
- April 28, 2022 · Voluntary: Firm initiated
- Classified
- May 3, 2022
- Reported
- May 11, 2022
- Ended
- June 21, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Alprazolam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.